Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Investor Growth Capital (IGC) is a venture capital firm that specializes in growth-stage investments within the healthcare and technology sectors. As a subsidiary of Investor AB, a leading Swedish investment company controlled by the Wallenberg family, IGC utilizes an evergreen capital structure to support long-term growth in its portfolio companies. The firm's healthcare focus includes biotechnology, medical technology, and healthcare services across North America, Europe, and Asia. While its operations have been largely integrated into Investor AB's broader investment framework, IGC remains a significant name in life science investing. The firm provides both financial capital and strategic guidance to help innovative healthcare companies scale globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investor Growth.